Chris Abell

Chris Abell
Abell in 2016
Born
Christopher Abell

(1957-11-11)11 November 1957
Died26 October 2020(2020-10-26) (aged 62)
NationalityBritish
EducationUniversity of Cambridge (BA, MA, PhD)
Known forAstex[3]
biosynthesis as targets for the rational design of antimicrobials; fragment-based approaches to enzyme inhibition; and biological nanotechnology
AwardsHickinbottom Award (1991)
Scientific career
FieldsBiological chemistry
InstitutionsUniversity of Cambridge
Brown University
ThesisPolyketide biosynthesis (1982)
Doctoral advisorJames Staunton
Doctoral studentsShankar Balasubramanian[1]
Alessio Ciulli[2]
Websitewww.ch.cam.ac.uk/person/ca26

Christopher Abell (11 November 1957[4] – 26 October 2020[5]) was a British biological chemist who was a professor of biological chemistry at the Yusuf Hamied Department of Chemistry and Todd-Hamied Fellow of Christ's College, Cambridge.[6] On his 2016 election to the Royal Society, Abell's research was described as having "changed the face of drug discovery."[7]

  1. ^ Balasubramanian, Shankar (1991). Studies on the reaction mechanism of chorismate synthase. lib.cam.ac.uk (PhD thesis). University of Cambridge. OCLC 60112382. EThOS uk.bl.ethos.386780.
  2. ^ Ciulli, Alessio (2006). Biophysical studies of protein-ligand interactions. lib.cam.ac.uk (PhD thesis). University of Cambridge. EThOS uk.bl.ethos.613799.
  3. ^ "Christopher ABELL - Personal Appointments (free information from Companies House)". beta.companieshouse.gov.uk.
  4. ^ Abell, Prof Christopher. In Debrett's People of Today 2012 (accessed 15 January 2012) (subscription required)
  5. ^ Professor Chris Abell FRS, FMedSci (1957 - 2020), Department of Chemistry, University of Cambridge, 27 October 2020, retrieved 15 November 2020
  6. ^ "Scientific Advisory Board". 7 April 2013. Archived from the original on 7 April 2013.
  7. ^ 50 leading scientists elected as Fellows of Royal Society, 29 April 2016, retrieved 2 September 2016